The U.S. Food and Drug Administration’s Center for Veterinary Medicine is announcing new resources for people interested in the development of intentional genomic alterations in animals. These include a pre-recorded, on-demand webinar about the agency’s risk-based review process for IGAs in animals that may pose low risk, as well as revamped web resources for biotechnology products at CVM.
During the webinar, FDA presenters will provide an overview of the agency’s recent determination of low risk for the marketing of…
